Spyre Therapeutics (SYRE) Tax Provisions (2021 - 2025)
Spyre Therapeutics (SYRE) posted Tax Provisions of -$15000.0 for Q1 2025, down 1600.0% on a QoQ basis from $1000.0 in Q4 2024, and down 146.88% year-over-year from $32000.0 in Q1 2024.
Spyre Therapeutics (SYRE) Tax Provisions (2021 - 2025) Analysis & Trends
Spyre Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at -$15000.0 for Q1 2025.
- Quarterly Tax Provisions fell 146.88% year-over-year to -$15000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$15000.0 (down 129.41% YoY) and the FY2025 annual result came in at -$15000.0, down 129.41% from the prior year.
- Tax Provisions was -$15000.0 for Q1 2025 at Spyre Therapeutics, down from $1000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $92000.0 in Q2 2021 and bottomed at -$209000.0 in Q3 2022.
- A 5-year average of -$846.15 and a median of $9000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 903.85% — and 2024, when it soared 500.0%.
- Spyre Therapeutics' Tax Provisions stood at $23000.0 in 2021, then surged by 65.22% to $38000.0 in 2022, then slumped by 92.11% to $3000.0 in 2023, then plunged by 66.67% to $1000.0 in 2024, then tumbled by 1600.0% to -$15000.0 in 2025.
- Business Quant data shows SYRE's Tax Provisions at -$15000.0 in Q1 2025, $1000.0 in Q4 2024, and $18000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | -209,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 92,000.00 |